LINK TO PUBMED ARTICLES FOR DR. MAKER
http://www.ncbi.nlm.nih.gov/pubmed/?term=ajay+makerORIGINAL ARTICLES (PEER REVIEWED)
• Shambaugh GE, Maker AV, Radosevich JA. Rapid Simultaneous Determination of Protein and Salt Concentrations in Ion-Exchange Fractions. Biotechniques. 19(5):725-8. 1995.
• Eisenberg ML, Maker AV, Slezak L, Nathan J, Sritharan K, Jena BP, Geibel JP, Andersen DK. Insulin Receptor (IR) and Glucose Transporter 2 (GLUT2) Proteins Form a Complex on the Rat Hepatocyte Membrane. Cellular Physiology and Biochemistry. 15(1-4):51-8, 2005.
• Ajay V. Maker and Dennis P. Orgill. Rapid Acute Amiodarone Induced Hepatotoxicity in a Burn Patient. Journal of Burn and Rehabilitation. 26(4):341-3. 2005.
• Ajay V. Maker and Dao Nguyen. Malignant Pleural Effusions as Viewed Through the Thoracoscope. Annals of Thoracic Surgery. 80(5):1941. 2005.
• Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA. Tumor Regression and Autoimmunity in Patients Treated with CTLA-4 Blockade and IL-2: A Phase I/II Study. Annals of Surgical Oncology. 12(12):1005-16. 2005.
• Aisner D, Maker AV, Rosenberg SA, Berman D. Loss of S100 Antigenicity in Metastatic Melanoma. Human Pathology. 36(9):1016-9. 2005.
• Attia P, Maker AV, Haworth LR, Freezer-Rogers L, Rosenberg, SA. Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denilukin Diftitox, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients with Melanoma. Journal of Immuntherapy. 28(6):582. 2005.
• Attia P, Phan GQ, Maker AV, Yang JC, Sherry RM, Topalian SL, Restifo NP, Haworth LR, Levy C, Freezer LJ, Morton KE, Mavroukakis SA, Yellin M, Rosenberg SA. Autoimmunity Correlates with Tumor Regression in Patients with Metastatic Melanoma Treated with anti-CLTA-4. Journal of Clinical Oncology. 23(25):6043-53. 2005.
• Maker AV, Attia P, Rosenberg SA. Analysis of the Cellular Mechanism of Anti-Tumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade. Journal of Immunology. 175(11):7746-54. 2005.
• Attia P, Powell DJ Jr, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA. Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. Journal of Immunotherapy. 29(2):208-14. 2006.
• Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Yellin M, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SA. Intra-patient Dose Escalation of Anti-CTLA-4 Antibody in Patients with Metastatic Melanoma. Journal of Immunotherapy. 29(4):455-463. 2006.
• Maker AV, Raut C, Lee L, Clancy T, Russell S, Swanson R. Cytology from Pancreatic Cysts is of Marginal Utility in Surgical Decision Making. Annals of Surgical Oncology. 15(11):3187-92. 2008.
• Maker AV, Warth JA, Zinner MJ. Novel Presentation of a Familial Pancreatic Cancer Syndrome. Journal of Gastrointestinal Surgery. 13(6):1151-4. 2009.
• Rudloff U, Maker AV, Brennan M, Allen P, Randomized Controlled Trials in Pancreatic Cancer. In: Surgical Oncology Clinics of North America. 19(1):115-150.2010.
• Maker AV, Katabi N, Gonen M, DeMatteo RP, D’Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen P. Cyst Fluid Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas (IPMN). Ann Surg Onc. 18(1):199.2011.
• Maker AV, Katabi N, Schattner M, Klimstra, D, Jarnagin WR, Allen P. Cyst Fluid Cytokines Distinguish Low and High Risk Intraductal Papillary Mucinous Neoplasms (IPMN). Clinical Cancer Research. 17(6):1502. 2011.
• Maker AV, Gayet B. Totally laparoscopic left lateral sectorectomy for hepatic malignancies: A modified technique. J of Gastrointest Sur. 15(9):1650. 2011
• Maker AV, Oxenberg J, Butte J, Kuk D, Gonen M, Fong Y, DeMatteo RP, D’Angelica MI, Allen P, Jarnagin WR. Is Port Site Resection Necessary in the Surgical Management of Gallbladder Carcinoma? Ann Surg Onc. Feb; 19(2):409-17. 2012.
• Li L, Jayaram S, Ganesh L, Qian Q, Rotmensch J, Maker AV, Prabhakar BS. Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells. American J Obstetrics & Gynecology. 205(4):362.e12-25. 2011.
• Maker AV, Maker VK. Malignant Masquerade of Xanthogranulomatous Cholecystitis on Intraoperative Ultrasound of the Liver. J Surg Onc. Sep 15;106(4):525-6. 2012.
• Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gonen M, Jarnagin WR, Fong Y, D’Angelica MI, Dematteo RP. Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 20(3):946-55. 2013.
• Maker VK, Zahedi MM, Villines D, Maker AV. Can we predict which residents are going to pass/fail the oral boards? J Surg Educ. 69(6):705-13. 2012.
• Valladolid G, Adams L,Weisenberg E, Maker VK, Maker AV. Primary Hepatic Lymphoma Presenting As an Isolated Solitary Hepatic Cyst. J Clin Onc. 31(2):e21-3.2013.
• Avraham J, Villenes D, Maker VK, August C, Maker AV. Survival after resection of malignant eccrine carcinoma: Risk factors and trends in outcomes for 1024 patients. J Surg Oncol. 108(1):57-62. 2013.
• Qin JZ, Upadhyay V. Prabhakar B, Maker AV. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases. Journal of Translational Medicine. 11(1):70.2013.
• Turner A., Li L, Pilli T, Qian L, Wiley EL, Setty S, Christov K, Ganesh L, Maker AV, Li P, Kanteti P,
• Das Gupta TK, Prabhakar BS. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells. PLoS One. 8(2):e56817.2013.
• Maker AV and Jarnagin W. Reply to “Port site resection in the surgical management of incidental gallbladder cancer: a still inconclusive question.” Annals of Surgical Oncology.(1/21/13)
• Kaminski JP, Maker VK, Maker AV. Review: Management of gastrointestinal malignancy in patients with prior jejunoileal bypass. Journal of the American College of Surgeons. 217(5):929-39.2013.
• Calata JF, Sukerkar AN, August CZ, Maker AV. Benign adrenal hemangiomas may mimic metastases on positron emission tomography (PET). Clinical Nuclear Medicine. 38(11):888-90. 2013.
• Maker AV. A Technique for Laparoendoscopic Resection of Posterior Fundic Gastric GISTs without Need for a Gastrotomy Annals of Surgical Oncology.20(13):4238. 2013.
• Ito H, Mo Q, Qin L, Viale A, Maithel S, Maker AV, Shia J, Kingham P, Allen P, DeMatteo R, Fong Y, Jarnagin W, D’Angelica MI, Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. PLoSOne. 8(12):e81680. 2013.
• Li LC, Wang Y, Carr R, Haddad CS, Li Z, Qian L, Oberholzer J, Maker AV, Wang Q, Prabhakar BS, IG20/MADD Plays a Critical Role in Glucose-Induced Insulin Secretion. Diabetes. 63(5):1612-23. 2014. PMID: 24379354
• Valladolid G, Sundaresan R, Weisenberg E, Maker AV. Calcifying Fibrous Tumor of the Small Intestine with Castleman-like Lymphadenopathy. Journal of Gastrointestinal Surgery.18(6):1205-8. 2014. PMID: 24452381
• Choi JJ, Sinada-Bottros L, Maker AV, Weisenberg E. Dedifferentiated gastrointestinal stromal tumor arising de novo from the small intestine.Pathol Res Pract. 210(4):264-6. 2014. PMID: 24484970
• Kitano M, Maker AV, Lanier BJ, Danforth DN, Kammula US. Appendicitis Secondary to Metastatic Melanoma: Review of the National Institutes of Health Experience. JAMA Surgery. 149(7):735-8. 2014. PMID: 24871401
• Maker AV, Carrara S, Jamieson NB, Pelaez-Luna M, Lennon A, Dal Molin M, Scarpa A, Frulloni L, Brugge WR. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas (IPMN): A critical review from the International Expert Meeting on Pancreatic Branch-Duct-IPMNs. Journal of the American College of Surgeons. 220(2):243-253.2015. PMID: 25592469
• Maker AV, Ito H, Mo Q, Weisenberg E, Qin L, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D’Angelica MI. Genetic evidence that intratumoral T-cell proliferation and activation is associated with recurrence and survival following resection of colorectal liver metastases. Cancer Immunology Research. 3(4):380-8. 2015. PMID: 25600439
• Maker AV. Tailoring GIST Therapy: Biology is Still King. JAMA Surgery. 150(4):306-7.2015. PMID: 25671489
• Pardiwalla K, Maker VK, Maker AV. Operative Management of Portal Annular Pancreas During Pancreaticoduodenectomy. Surgery. pii: S0039-6060(14)00613-8. 2015. PMID: 26144878
• Ajay V. Maker and Lary Iteld. Closure of large melanoma excision defects on the sole of the foot using glaborous skin – The end of the flap? Annals of Surgical Oncology. 22(12):4081-2. 2015. PMID: 25749930
• Ajay V. Maker and Ryan Carr. Techniques to Perform a Laparoscopic Right Adrenalectomy for Metastases Abutting the Liver, Renal Vein, and Posterior Vena Cava. Surgical Endoscopy.2015 (epub July 3) PMID: 26139482
• Kopanja D, Pandey A, Kiefer M, Wang Z, Chandan N, Carr JR, Franks R, Yu DY, Guzman G, Maker A, Raychaudhuri P. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. Journal of Hepatology. Aug;63(2):429-36. 2015. PMID: 25828473
• August C, Maker AV, Weisenberg E. Simultaneous Occurrence of Glandular and Neuroendocrine Components in Lymph Node Metastasis of Gastric MANEC. Int J Surg Pathol. 23(5):375-6. 2015. PMID: 25807951
• Bhagwandin S, Weisenberg ES, Ozer H, Maker AV. Symptomatic Massive Splenomegaly in Persistent Polyclonal B-cell Lymphocytosis Requiring Splenectomy Journal of Clinical and Medical Case Reports. 1(3). pii: 1017. 2015. PMID: 26693179
• Maker AV, Prabhakar B, Pardiwala K. The potential of intralesional rose bengal to stimulate T-cell mediated anti-tumor responses. J Clin Cell Immunol. 6(4). pii: 343. 2015. PMID: 26618054
• Maker AV. Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment – Evidence to turn on the LIGHT. Oncoimmunology. Epub Aug 12, 2015. DOI:10.1080/2162402X.2015.1069937.
• Maker AV, Valbuena V, Maker VK. A Minimally Invasive Technique to Obtain Optimal Tumor Margins in Anatomically Confined Locations using a Contoured Stapler. Ann Surg Oncol. Epub 2015 Aug 12. PMID: 26265368BOOKS/CHAPTERS
• Ajay V. Maker, Studies on the Molecular Mechanics of Insulin Resistance in Pancreatogenic Diabetes. M.D. Thesis. Permanent Collection, Sterling Library of Medicine, New Haven, CT. 2001.
• Ajay V. Maker, The Clinical Years. In: Future M.D. Writers Club Press, 1st ed., 2002.
• Desai S, Barshes N, Maker AV, Surgery Clerkship: 150 Biggest Mistakes and How To Avoid Them. MD2b Press, Houston, TX. 2005. (editor)
• Ajay V. Maker and Michael D’Angelica, Hepatic Resection. In: Surgical management of hepatobiliary and pancreatic disorders, 2nd Edition. 2012.
• Maker AV, Covey A, Jarnagin W, Liver Anatomy: Variant Venous Anatomy – Implications for Resection. In: Venous Embolization of the Liver: Radiological and Surgical Practice. 2012.
• Ajay V. Maker. Malignant Ascites. In: Principles and Practice of Oncology, 10th Ed., Editors Davita, Hellman, Rosenberg. 2014.
• Ajay V. Maker. Advanced Pancreatic Cancer Discovered at Operation. In: Difficult Decisions in Hepatobiliary and Pancreatic Surgery – An Evidence Based Approach. 1st Ed. Editor Jeff Matthews. 2015.